Wave Life Sciences (WVE) Other Non-Current Assets (2015 - 2026)
Wave Life Sciences (WVE) posted Other Non-Current Assets of $386000.0 for Q1 2026, up 2312.5% on a QoQ basis from $16000.0 in Q4 2025, and down 13.84% year-over-year from $448000.0 in Q1 2025.
Wave Life Sciences (WVE) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Wave Life Sciences' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $386000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 13.84% year-over-year to $386000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $386000.0 (down 13.84% YoY) and the FY2025 annual result came in at $16000.0, down 99.57% from the prior year.
- Other Non-Current Assets was $386000.0 for Q1 2026 at Wave Life Sciences, up from $16000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.8 million in Q2 2025 and bottomed at $16000.0 in Q4 2025.
- A 5-year average of $1.7 million and a median of $900000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 2316.77% — and 2025, when it slumped 99.57%.
- Wave Life Sciences' Other Non-Current Assets stood at $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then increased by 1.62% to $3.8 million in 2024, then slumped by 99.57% to $16000.0 in 2025, then surged by 2312.5% to $386000.0 in 2026.
- Business Quant data shows WVE's Other Non-Current Assets at $386000.0 in Q1 2026, $16000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 386,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 386,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 448,000.00 |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 868,000.00 |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 3.65 Mn |
| Mar 31, 2022 | 685,000.00 |
| Dec 31, 2021 | 3.70 Mn |
| Sep 30, 2021 | 3.65 Mn |
| Jun 30, 2021 | 2.30 Mn |